Abstract
Background
Recently, many plastic surgeons have been using adipogenic-differentiated cell implantation for remodeling scars in patients. However, this technique is not a long-term solution because implanted cells disappear gradually. Therefore, we investigated a method to increase the grafted cell preservation rate by using an effective adjuvant, botulinum toxin.
Methods
The adipogenic-differentiated cells were subcutaneously injected in the dorsal area of C57/BL6 mice with or without botulinum toxin. Two and six weeks later we analyzed the residual volume and confirmed the characteristics of the implanted cells by real-time RT-PCR and immunohistochemistry.
Results
Two and six weeks after transplantation we found that the residual volume of the transplantation site was higher in the botulinum toxin-treated group than in the untreated group. We also confirmed that the residual transplanted area has characteristics of adipogenic tissue by histological analysis. Next, to determine the mechanism related to the enhanced preservation rate of grafted cells via treatment with botulinum toxin, we performed immunohistochemical staining for the angiogenesis-related marker CD31. We found that CD31 expression was higher in the botulinum toxin-treated group than in the untreated group.
Conclusion
We have shown that in vivo grafted adipocyte cell preservation can be enhanced by treatment with botulinum toxin as an adjuvant. We suggest that botulinum toxin further increases this graft preservation rate by enhancing angiogenesis.
Similar content being viewed by others
References
Ersek RA (1991) Transplantation of purified autologous fat: a 3-year follow-up is disappointing. Plast Reconstr Surg 87:219–227; discussion 228
Ullmann Y, Hyams M, Ramon Y, Beach D, Peled IJ, Lindenbaum ES (1998) Enhancing the survival of aspirated human fat injected into nude mice. Plast Reconstr Surg 101:1940–1944
Cho SW, Kim SS, Rhie JW, Cho HM, Choi CY, Kim BS (2005) Engineering of volume-stable adipose tissues. Biomaterials 26:3577–3585
Eppley BL, Snyders RV Jr, Winkelmann T, Delfino JJ (1992) Autologous facial fat transplantation: improved graft maintenance by microbead bioactivation. J Oral Maxillofac Surg 50:477–482; discussion 482-483
Choi YS, Park SN, Suh H (2005) Adipose tissue engineering using mesenchymal stem cells attached to injectable PLGA spheres. Biomaterials 26:5855–5863
Hemmrich K, von Heimburg D, Rendchen R, Di Bartolo C, Milella E, Pallua N (2005) Implantation of preadipocyte-loaded hyaluronic acid-based scaffolds into nude mice to evaluate potential for soft tissue engineering. Biomaterials 26:7025–7037
Jeon O, Ryu SH, Chung JH, Kim BS (2005) Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin. J Control Release 105:249–259
Kimura Y, Ozeki M, Inamoto T, Tabata Y (2003) Adipose tissue engineering based on human preadipocytes combined with gelatin microspheres containing basic fibroblast growth factor. Biomaterials 24:2513–2521
Ashkenazi A, Silberstein S (2008) Botulinum toxin type A for the treatment of headache: why we say yes. Arch Neurol 65:146–149
Lew HL, Lee EH, Castaneda A, Klima R, Date E (2008) Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study. Arch Phys Med Rehabil 89:75–80
Nix WA (2007) Botulinum toxin in chronic myofascial pain. Schmerz 21:467–468
Beer K, Waibel J (2007) Botulinum toxin type A enhances the outcome of fractional resurfacing of the cheek. J Drugs Dermatol 6:1151–1152
Lee H, Saladi RN, Fox JL (2008) Cohort study on patient response to botulinum toxin cosmetic therapy. J Cosmet Dermatol 7:39–42
Jin R, Rummel A, Binz T, Brunger AT (2006) Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity. Nature 444:1092–1095
Morris JL, Jobling P, Gibbins IL (2001) Differential inhibition by botulinum neurotoxin A of cotransmitters released from autonomic vasodilator neurons. Am J Physiol Heart Circ Physiol 281:H2124–H2132
Morris JL, Jobling P, Gibbins IL (2002) Botulinum neurotoxin A attenuates release of norepinephrine but not NPY from vasoconstrictor neurons. Am J Physiol Heart Circ Physiol 283:H2627–H2635
Tang-Liu DD, Aoki KR, Dolly JO, de Paiva A, Houchen TL, Chasseaud LF, Webber C (2003) Intramuscular injection of 125I-botulinum neurotoxin-complex versus 125I-botulinum-free neurotoxin: time course of tissue distribution. Toxicon 42:461–469
Christman KL, Fang Q, Yee MS, Johnson KR, Sievers RE, Lee RJ (2005) Enhanced neovasculature formation in ischemic myocardium following delivery of pleiotrophin plasmid in a biopolymer. Biomaterials 26:1139–1144
Ehrbar M, Djonov VG, Schnell C, Tschanz SA, Martiny-Baron G, Schenk U, Wood J, Burri PH, Hubbell JA, Zisch AH (2004) Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth. Circ Res 94:1124–1132
Saban MR, Towner R, Smith N, Abbott A, Neeman M, Davis CA, Simpson C, Maier J, Mémet S, Wu XR, Saban R (2007) Lymphatic vessel density and function in experimental bladder cancer. BMC Cancer 7:219
Illouz YG (1988) Present results of fat injection. Aesthetic Plast Surg 12:175–181
Patrick CW Jr, Chauvin PB, Hobley J, Reece GP (1999) Preadipocyte seeded PLGA scaffolds for adipose tissue engineering. Tissue Eng 5:139–151
Patrick CW Jr, Zheng B, Johnston C, Reece GP (2002) Long-term implantation of preadipocyte-seeded PLGA scaffolds. Tissue Eng 8:283–293
Smahel J, Meyer V, Schutz K (1990) Vascular augmentation of free adipose tissue grafts. Eur J Plast Surg 13:742–748
Cho SW, Gwak SJ, Kang SW, Bhang SH, Won Song KW, Yang YS, Choi CY, Kim BS (2006) Enhancement of angiogenic efficacy of human cord blood cell transplantation. Tissue Eng 12:1651–1661
Ansiaux R, Baudelet C, Cron GO, Segers J, Dessy C, Martinive P, De Wever J, Verrax J, Wauthier V, Beghein N, Grégoire V, Buc Calderon P, Feron O, Gallez B (2006) Botulinum toxin potentiates cancer radiotherapy and chemotherapy. Clin Cancer Res 12:1276–1283
Acknowledgments
This work was supported by a Korea Research Foundation grant funded by the Korean Government (MOEHRD) (KRF-2006-005-J02202), a grant from the Korea Health 21 R&D project, Ministry of Health & Welfare, Republic of Korea (A050569), and the Seoul Research and Business Development Program (10582).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Daeho Cho and Sa Ik Bang contributed equally to this work.
Rights and permissions
About this article
Cite this article
Jung, M.K., Song, S.B., Cheon, S.Y. et al. Botulinum Toxin Enhances the Implantation Effect of Adipocytes in C57/BL6 Mice. Aesth Plast Surg 33, 722–729 (2009). https://doi.org/10.1007/s00266-009-9394-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00266-009-9394-0